Casdin Partners GP, LLC

Director, 10% OwnerSTANDARD BIOTOOLS INC. (LAB) · full profile →Form 4 · filed Nov 12, 2025
Net Buying
Open-Market Buys
$1.4M
Open-Market Sells
$0
Net Open-Market Flow
$1.4M
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 12, 2025Buy(P)375K$1.19$446K62.0M
Nov 11, 2025Buy(P)300K$1.20$360K61.7M
Nov 10, 2025Buy(P)275K$1.17$322K61.4M
Nov 7, 2025Buy(P)225K$1.12$252K61.1M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000919574-25-006597) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about LAB insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0000919574-25-006597"
Ask your agent
Use Arkolith to summarize insider buying and selling at STANDARD BIOTOOLS INC.
over the last 90 days and cite the filings.